Key result
Isoproterenol regulates Na-K-ATPase via p70S6k in alveolar epithelial cells, a process that is inhibited by rapamycin and the MEK1/2 inhibitor U-0126.
This study provides the first evidence that the beta-adrenergic agonist isoproterenol regulates Na-K-ATPase via the p70S6k pathway in alveolar epithelial cells.
Answers are grounded in this paper and cite their sources.
p70S6k mediates isoproterenol effects on alveolar Na-K-ATPase; leaves open its role in lung fluid clearance in vivo.
We have recently reported that the beta-adrenergic agonist isoproterenol regulates the alveolar epithelial cell Na-K-ATPase via MAPK/extracellular signal-regulated kinase and rapamycin-sensitive pathways. Here we report that isoproterenol phosphorylated the protein S6 kinase (p70S6k) in alveolar epithelial cells, which was inhibited by both rapamycin and the MEK1/2 inhibitor U-0126. In alveolar epithelial cells transfected with a p70S6k dominant negative construct, isoproterenol did not increase Na-K-ATPase total protein expression, whereas in cells transfected with a rapamycin-resistant mutant, the isoproterenol-mediated increase in Na-K-ATPase was not prevented by rapamycin. Accordingly, we provide here first evidence that isoproterenol regulates Na-K-ATPase via p70S6k in alveolar epithelial cells.
No takes yet. Share an insight, caveat, or question.
Pesce et al. (2003) studied this question. Isoproterenol was evaluated on Na-K-ATPase total protein expression and p70S6k phosphorylation. Isoproterenol regulates Na-K-ATPase via p70S6k in alveolar epithelial cells, a process that is inhibited by rapamycin and the MEK1/2 inhibitor U-0126.
Synapse has enriched 10 related papers. Consider them for comparative context: